PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.77%
Revenue decline while 3141.T shows 3.98% growth. Joel Greenblatt would examine competitive position erosion.
-4.28%
Cost reduction while 3141.T shows 2.72% growth. Joel Greenblatt would examine competitive advantage.
-6.75%
Gross profit decline while 3141.T shows 7.01% growth. Joel Greenblatt would examine competitive position.
-2.08%
Margin decline while 3141.T shows 2.91% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.81%
Similar other expenses growth to 3141.T's 19.18%. Walter Schloss would investigate industry patterns.
1.66%
Operating expenses growth less than half of 3141.T's 3.98%. David Dodd would verify sustainability.
-3.32%
Total costs reduction while 3141.T shows 3.06% growth. Joel Greenblatt would examine advantage.
-4.35%
Interest expense reduction while 3141.T shows 19.61% growth. Joel Greenblatt would examine advantage.
15.78%
Similar D&A growth to 3141.T's 20.12%. Walter Schloss would investigate industry patterns.
-31.53%
EBITDA decline while 3141.T shows 26.64% growth. Joel Greenblatt would examine position.
-28.10%
EBITDA margin decline while 3141.T shows 21.79% growth. Joel Greenblatt would examine position.
-35.54%
Operating income decline while 3141.T shows 27.39% growth. Joel Greenblatt would examine position.
-32.31%
Operating margin decline while 3141.T shows 22.51% growth. Joel Greenblatt would examine position.
10.94%
Other expenses growth 50-75% of 3141.T's 16.24%. Bruce Berkowitz would examine cost efficiency.
-31.62%
Pre-tax income decline while 3141.T shows 26.69% growth. Joel Greenblatt would examine position.
-28.20%
Pre-tax margin decline while 3141.T shows 21.84% growth. Joel Greenblatt would examine position.
-30.25%
Tax expense reduction while 3141.T shows 31.97% growth. Joel Greenblatt would examine advantage.
-32.23%
Net income decline while 3141.T shows 23.72% growth. Joel Greenblatt would examine position.
-28.84%
Net margin decline while 3141.T shows 18.98% growth. Joel Greenblatt would examine position.
-32.22%
EPS decline while 3141.T shows 23.68% growth. Joel Greenblatt would examine position.
-32.22%
Diluted EPS decline while 3141.T shows 23.86% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.